THE DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS: A NEW LOOK

Download full text PDF
Issue: 
10
Year: 
2017

Professor A. Solopova, MD; E. Chukanova I.M. Sechenov First Moscow State Medical University (Sechenov University)

The paper presents the current principles of the diagnosis and treatment of endometriosis, as well as the latest methods that are only to be introduced into daily gynecological practice.
Keywords: 
obstetrics and gynecology
endometriosis
treatment
diagnosis

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Dunselman G., Vermeulen N., Becker C. et al. ESHRE guideline: management of women with endometriosis // Hum. Reprod. – 2014; 29 (3): 400–12.
  2. Guerriero S., Ajossa S., Gerada M. et al. Diagnostic value of transvaginal ‘tenderness-guided’ ultrasonography for the prediction of location of deep endometriosis // Hum. Reprod. – 2008; 23 (11): 2452–7.
  3. Berker B., Seval M. Problems with the diagnosis of endometriosis // Womens Health (Lond). – 2015; 11 (5): 597–601.
  4. Lee N., Kim S., Kim K. et al. Diffusion-weighted magnetic resonance imaging in the differentiation of endometriomas from hemorrhagic cysts in the ovary // Acta Radiologica. – 2016; 57 (8): 998–1005.
  5. Panteleeva O.G., Kuznetsova I.A., Kachalina O.V. i dr. Opticheskaja kogerentnaja tomografija kak instrument reproduktivnoj ginekologii // Sovremen. tehnol. v meditsine. – 2015; 1: 89–96.
  6. Marzhevskaja A.M., Rischuk S.V., Gusev S.N. i dr. Reproduktivnye narushenija u bol'nyh endometriozom: etiologija, patogenez, vozmozhnosti korrektsii // BONTs UrO RAN. – 2014; 3: 1–42.
  7. Jarmolinskaja M.I., Molotkov A.S., Denisova V.M. Rol' matriksnyh metalloproteinaz v patogeneze genital'nogo endometrioza // Zhurn. akusherstva i zhenskih boleznej. – 2012; 61 (2): 92–100.
  8. Turkyilmaz E., Yildirim M., Cendek B. et al. Evaluation of oxidative stress markers and intra-extracellular antioxidant activityes in patients with endometriosis // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2016; 199: 164–8.
  9. Sorokina A.V., Radzinskij V.E., Morozov S.G. i dr. Informativnost' immunologicheskih pokazatelej v syvorotke krovi dlja diagnostiki adenomioza // Doktor.ru. – 2012; 1 (69): 7–9.
  10. Vlijanie hirurgicheskogo lechenija endometriomy jaichnikov na ovarial'nyj rezerv: itogi sistematicheskogo obzora i metaanaliza // Probl. zhenskogo zdorov'ja. – 2012; 3.
  11. Vercellini P., Eskenazi B., Consonni D. et al. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis // Hum. Reprod. Update. – 2011; 17 (2): 159–70.
  12. Kaminski K., Fiegler P., Marr J. et al. Treatment of endometriosis with dienogest: preliminary report // Ginekol. Pol. — 2001; 72: 299–304.
  13. Mita S., Shimizu Y., Sato A. et al. Dienogest in hibits nervegrowth factor expression induced by tumor necrosis factor-α or interleukin-1β // Fertil. Steril. – 2014; 101 (2): 595–601.
  14. Carr B., Dmowski W., Brien C. et al. Anoral-Gn-R-Hantagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density // Reprod. Sci. – 2014; 21 (11): 1341–51.
  15. Nakata D., Masaki T., Tanaka A. et al. Suppression of the hypothalamic-pituitary-gonadalaxisby TAK-385 (relugolix), a novel, investigational, orallyactive, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRHreceptorknock-inmice // Eur. J. Pharmacol. – 2014; 723: 167–74.
  16. Delvoux B., D'hooghe T., Kyama C. et al. Inhibitionoftype 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions // J. Clin. Endocrinol. Metabol. – 2014; 99 (1): 276–84.
  17. Kulak J., Fischer C., Komm B. et al. Treatment with bazed oxifene, a selective estrogen receptor modulator, causes regression of endometriosisin a mouse model // Endocrinology. – 2011; 152 (8): 3226–32.
  18. Zhao Y., Gong P., Chen Y. et. al. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis // Sci. Translat. Med. – 2015; 7 (271): 1–14.
  19. Imesch P., Samartzis E., Dedes K. et al. Histone deacetylase inhibitors down-regulate G-protein- coupled estrogen receptor and the GPER-antagonist G-15 inhibits prolife rationin endometriotic cells // Fertil. Steril. – 2013; 100: 770–6.
  20. Benagiano G., Bastianelli C., Farris M. et al. Selective progesterone receptor modulators: an update // Expert Opin. Pharmacother. – 2014; 15 (10): 1403–15.